The benefits of a new precision medicine initiative, being piloted at Sydney Children’s Hospitals Network (SCHN), are already being seen in children and families with rare genetic diseases.
The program, Gene2Care, aims to improve the standard of care, including enhanced diagnoses and access to management and treatment. The family-centred program, funded by Luminesce Alliance, combines the effo...
